Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, Calgary, AB, Canada.
Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Front Cell Infect Microbiol. 2023 Jan 6;12:1083090. doi: 10.3389/fcimb.2022.1083090. eCollection 2022.
While developing vaccines targeting surface transferrin receptor proteins in Gram-negative pathogens of humans and food production animals, the common features derived from their evolutionary origins has provided us with insights on how improvements could be implemented in the various stages of research and vaccine development. These pathogens are adapted to live exclusively on the mucosal surfaces of the upper respiratory or genitourinary tract of their host and rely on their receptors to acquire iron from transferrin for survival, indicating that there likely are common mechanisms for delivering transferrin to the mucosal surfaces that should be explored. The modern-day receptors are derived from those present in bacteria that lived over 320 million years ago. The pathogens represent the most host adapted members of their bacterial lineages and may possess factors that enable them to have strong association with the mucosal epithelial cells, thus likely reside in a different niche than the commensal members of the bacterial lineage. The bacterial pathogens normally lead a commensal lifestyle which presents challenges for development of relevant infection models as most infection models either exclude the early stages of colonization or subsequent disease development, and the immune mechanisms at the mucosal surface that would prevent disease are not evident. Development of infection models emulating natural horizontal disease transmission are also lacking. Our aim is to share our insights from the study of pathogens of humans and food production animals with individuals involved in vaccine development, maintaining health or regulation of products in the human and animal health sectors.
在针对人类和食品生产动物的革兰氏阴性病原体表面转铁蛋白受体蛋白开发疫苗时,源自其进化起源的共同特征为我们提供了如何在研究和疫苗开发的各个阶段进行改进的见解。这些病原体专门适应在其宿主的上呼吸道或泌尿生殖道的粘膜表面生存,并且依赖其受体从转铁蛋白中获取铁来生存,这表明可能存在将转铁蛋白递送到粘膜表面的共同机制,这些机制值得探索。现代受体源自于 3.2 亿多年前生活的细菌中的那些受体。病原体是其细菌谱系中最适应宿主的成员,它们可能具有使其与粘膜上皮细胞强烈关联的因素,因此可能存在于与细菌谱系中的共生成员不同的生态位中。细菌病原体通常过着共生的生活方式,这给相关感染模型的发展带来了挑战,因为大多数感染模型要么排除了定植的早期阶段,要么排除了随后的疾病发展,而阻止疾病发生的粘膜表面的免疫机制并不明显。缺乏模仿自然水平疾病传播的感染模型的发展。我们的目标是与参与疫苗开发、维护人类和动物健康部门的健康或产品监管的个人分享我们在人类和食品生产动物病原体研究方面的见解。